Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.

Litzow MR, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, Dipersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ.

Blood. 2010 Mar 4;115(9):1850-7. doi: 10.1182/blood-2009-10-249128. Epub 2009 Dec 23.

PMID:
20032503
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy.

Anderson JE, Gooley TA, Schoch G, Anasetti C, Bensinger WI, Clift RA, Hansen JA, Sanders JE, Storb R, Appelbaum FR.

Blood. 1997 Apr 1;89(7):2578-85. Review.

PMID:
9116305
[PubMed - indexed for MEDLINE]
Free Article
3.

A systematic overview of chemotherapy effects in acute myeloid leukaemia.

Kimby E, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):231-52. Review.

PMID:
11441935
[PubMed - indexed for MEDLINE]
4.

Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia?

Song KW, Lipton J.

Bone Marrow Transplant. 2005 Aug;36(3):183-91. Review.

PMID:
15937497
[PubMed - indexed for MEDLINE]
5.

Does matched unrelated donor transplantation have the same outcome as matched sibling transplantation in unselected patients?

Horowitz MM.

Best Pract Res Clin Haematol. 2012 Dec;25(4):483-6. doi: 10.1016/j.beha.2012.10.012. Epub 2012 Nov 20. Review.

PMID:
23200546
[PubMed - indexed for MEDLINE]
6.

Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.

Klimek VM.

Curr Opin Hematol. 2013 Mar;20(2):137-43. doi: 10.1097/MOH.0b013e32835d82e6. Review.

PMID:
23343830
[PubMed - indexed for MEDLINE]
7.

[Mini-transplant for acute myeloblastic leukemia and myelodysplastic syndrome].

Kanda Y.

Nihon Rinsho. 2003 Sep;61(9):1565-72. Review. Japanese.

PMID:
14515725
[PubMed - indexed for MEDLINE]
8.

Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS): how can we improve outcomes in the near future?

Phillips GL.

Leuk Res. 2012 Dec;36(12):1490-5. doi: 10.1016/j.leukres.2012.08.004. Epub 2012 Sep 3. Review.

PMID:
22954609
[PubMed - indexed for MEDLINE]
9.

Reduced-intensity conditioning transplantation in myeloid malignancies.

Storb R.

Curr Opin Oncol. 2009 Jun;21 Suppl 1:S3-5. doi: 10.1097/01.cco.0000357467.45843.ba. Review.

PMID:
19561410
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Optimizing management of myelodysplastic syndromes post-allogeneic transplantation.

Sockel K, Ehninger G, Hofbauer LC, Platzbecker U.

Expert Rev Hematol. 2011 Dec;4(6):669-80. doi: 10.1586/EHM.11.58. Review.

PMID:
22077530
[PubMed - indexed for MEDLINE]
11.

Therapy-related myeloid leukemia.

Godley LA, Larson RA.

Semin Oncol. 2008 Aug;35(4):418-29. doi: 10.1053/j.seminoncol.2008.04.012. Review.

PMID:
18692692
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Risk assessment before allogeneic hematopoietic cell transplantation for older adults with acute myeloid leukemia.

Sorror ML, Appelbaum FR.

Expert Rev Hematol. 2013 Oct;6(5):547-62. doi: 10.1586/17474086.2013.827418. Epub 2013 Oct 2. Review.

PMID:
24083472
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach.

Cornelissen JJ, Gratwohl A, Schlenk RF, Sierra J, Bornhäuser M, Juliusson G, Råcil Z, Rowe JM, Russell N, Mohty M, Löwenberg B, Socié G, Niederwieser D, Ossenkoppele GJ.

Nat Rev Clin Oncol. 2012 Oct;9(10):579-90. doi: 10.1038/nrclinonc.2012.150. Epub 2012 Sep 4. Review.

PMID:
22949046
[PubMed - indexed for MEDLINE]
14.

The evolving challenge of therapy-related myeloid neoplasms.

Churpek JE, Larson RA.

Best Pract Res Clin Haematol. 2013 Dec;26(4):309-17. doi: 10.1016/j.beha.2013.09.001. Epub 2013 Oct 1. Review.

PMID:
24507808
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.

Sill H, Olipitz W, Zebisch A, Schulz E, Wölfler A.

Br J Pharmacol. 2011 Feb;162(4):792-805. doi: 10.1111/j.1476-5381.2010.01100.x. Review.

PMID:
21039422
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Hematopoietic stem cell transplantation and immunotherapy for pediatric acute myeloid leukemia: an open challenge.

Lucchini G, Bader P.

Expert Rev Hematol. 2014 Apr;7(2):291-300. doi: 10.1586/17474086.2014.878644. Review.

PMID:
24617334
[PubMed - indexed for MEDLINE]
17.

Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insights.

Platzbecker U.

Hematology Am Soc Hematol Educ Program. 2013;2013:522-8. doi: 10.1182/asheducation-2013.1.522. Review.

PMID:
24319227
[PubMed - indexed for MEDLINE]
Free Article
18.

Therapy-related myelodysplastic syndromes and acute leukemias.

Brusamolino E, Bernasconi C.

Leukemia. 1992 Nov;6 Suppl 4:23-5. Review. No abstract available.

PMID:
1434826
[PubMed - indexed for MEDLINE]
19.

Evidence-based mini-review: Should patients over the age of 60 with INT-2 or high-risk myelodysplastic syndrome undergo allogeneic stem cell transplantation prior to progression to acute myelogenous leukemia?

Schroeder MA, Blum W.

Hematology Am Soc Hematol Educ Program. 2010;2010:322-4. doi: 10.1182/asheducation-2010.1.322. Review.

PMID:
21239813
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pharmacological methods to reduce disease recurrence.

Craddock C.

Hematology Am Soc Hematol Educ Program. 2013;2013:63-9. doi: 10.1182/asheducation-2013.1.63. Review.

PMID:
24319164
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk